Fatty acids and idiopathic calcium nephrolithiasis

Urologia Internationalis

Volumn 75, Issue 2, 2005, Pages 97-101

  Baggio, Bruno ^a,b   Budakovic, Alessandro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; CALCIUM; FATTY ACID; FISH OIL; INDOMETACIN; PROSTAGLANDIN INHIBITOR;

BONE DENSITY; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BONE LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; HUMAN; HYPERCALCIURIA; IDIOPATHIC DISEASE; INTESTINE ABSORPTION; KIDNEY; LIPID COMPOSITION; LUMBAR SPINE; NEPHROLITHIASIS; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL MODEL; STONE FORMATION;

ANIMALS; CALCIUM; CALCIUM METABOLISM DISORDERS; DISEASE MODELS, ANIMAL; FATTY ACIDS; HUMANS; KIDNEY CALCULI; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 23944469872     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087161     Document Type: Review

References (40)

1. Iguchi M, Kataoka K, Kohri K, Yachiku T: Nutritional risk factors in calcium stone disease in Japan. Urol Int 1984;39:32-35.
2. Caruana RJ, Bucklew VMJ: Improvement of hypercalciuria, potassium wasting and hyperreninemia in incomplete distal renal tubular acidosis by indomethacin. Nephron 1979;24:232-234.
3. Buck AC, Sampson WF, Lote CJ, Blackock NJ: The influence of renal prostaglandins on glomerular filtration and calcium excretion in urolithiasis. Br J Urol 1981;53:485-491.
4. Buck AC, Lote CJ, Sampson WF: The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 1983;129:421-426.
5. Buck AC, Davies RL, Harrison T: The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrocalcinosis. J Urol 1991;14:188-194.
6. 2 in patients with idiopathic hypercalciuria. Clin Sci 1988;75:581-587.
7. 2 in patients with idiopathic hypercalciuria is a primary phenomenon. Clin Sci 1992;83:75-580.
8. Baggio B: Fatty acids, calcium and bone metabolism. J Nephrol 2002;15:601-604.
9. Baggio B, Gambaro G, Zambon S, et al: Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol 1996;7:613-620.
10. Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A: Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis. Lancet 1984;ii:12-14.
11. Baggio B, Gambaro G, Marchini F, et al: An inheritable anomaly of red-cell oxalate transport in 'primary' calcium nephrolithiasis correctable with diuretics. N Engl J Med 1986;314:599-604.
12. Baggio B, Gambaro G, Marchini F, et al: Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis. Clin Sci 1994;86:239-243.
13. Baggio B, Budakovic A, Nassuato MA, et al: Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000;8:1278-1284.
14. Bentler PM, Stein JA: Structural equation models in medical research. Stat Methods Med Res 1992;1:159-181.
15. Bentler MP: Covariance structure analysis: Statistical practice, theory, and directions. Annu Rev Psychol 1996;47:563-592.
16. Zerwekh JE, Reed-Gitomer BJ, Pak CYC: Pathogenesis of hypercalciuric nephrolithiasis. Endocrin Metab Clin North Am 2002;31:869-884.
17. Filipponi P, Mannarelli C, Pacifici R: Evidence for a prostaglandin mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 1988;43:61-66.
18. Nordin RW, Jee SS, High WB: The role of prostaglandins in bone in vivo. Prostaglandins Leukotrienes 1990;41:139-149.
19. Weisinger JR: New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone. Kidney Int 1996;49:1507-1518.
20. Hasanoglu A, Ercan ZS, Buyan N, Memioglu N, Hasanoglu E: Parathormone, 1,25 dihydroxyvitamin D and prostaglandin correlation in children with idiopathic hypercalciuria. Prostaglandins Leukot Essent Fatty Acids 1997;56:235-237.
21. 2+-ATPase in basolateral membranes from rat enterocytes. Prostaglandins Leukot Essent Fatty Acids 1999;61:25-27.
22. Bianchi G, Vezzoli G, Cusi D, et al: Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. N Engl J Med 1988;319:897-901.
23. Vezzoli G, Rubinacci A, Bianchin C, et al: Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 2003;42:1177-1183.
24. Priante G, Bordin L, Musacchio E, Clari G, Baggio B: Fatty acids and cytokine mRNA expression in human osteoblastic cells: A specific effect of arachidonic acid. Clin Sci 2002;102:403-409.
25. Pacifici R, Rothstein M, Rifas L, et al: Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990;71:138-145.
26. Manolagas SC, Jilka L: Bone marrow, cytokines and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-311.
27. Rothwell PJN, Green R, Blacklock NJ, Kavanagh JP: Does fish oil benefit stone formers? J Urol 1993;150:1391-1394.
28. Gambaro G, Bordoni A, Hrelia S, et al: Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels, and the urinary excretion of calcium and oxalate in the rat: Insight in calcium lithogenesis. J Lab Clin Med 2000;135:89-95.
29. Baggio B, Budakovic A, Priante G, et al: Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat: Insight into calcium lithogenesis. Nephron 2002;91:486-491.
30. Baggio B, Priante G, Brunati AM, Clari C, Bordin L: Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: Clinical implications in calcium oxalate nephrolithiasis. J Am Soc Nephrol 1999;10:S381-S384.
31. Naya Y, Ito H, Masai M, Yamaguchi K: Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU Int 2002;89:842-846.
32. Fisher S: Dietary polyunsaturated fatty acids and eicosanoid formation in humans. Adv Lipid Res 1989;23:169-198.
33. Davidson J: Lipid metabolism. Curr Opin Lipidol 1995;6:U65-U66.
34. Brenner RR: Factors influencing fatty acid chain elongation and desaturation; in Vergroesen AJ, Crawford M (eds): The Role of Fats in Human Nutrition, ed 2. London, Academic Press, 1989, pp 45-79.
35. Ratnayake WM, Sarwar G, Laffey P: Influence of dietary protein and fat on serum lipids and metabolism of essential fatty acids in rats. Br J Nutr 1997;78:459-467.
36. Rotily M, Leonetti F, Iovanna C, et al: Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis. Kidney Int 2000;57:1115-1123.
37. Del Vecchio FG, Preminger GM: Medical management of stone disease. Curr Opin Urol 2003;13:229-233.
38. Baggio B: Protein diet and hypercalciuria. Kidney Int 2004;65:1970.
39. Gibson RA, Sinclair AJ: Are Eskimos obligated carnivores? Lancet 1981;i:1100.
40. Modlin M: Urinary sodium and renal stones; in Hodgkinson A, Nordin BEC (eds): Renal Stone Symposium. London, Churchill, 1969, pp 2002-2220.